Loading CNXC…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("CNXC","financials")Full statements spill as a table. For one cell: =jivedata("CNXC","Revenue") or =jivedata("CNXC","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
CNXC • CIK 0001803599
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax | $7,114,706 | $9,618,900 | $9,825,771 | $9,969,468 |
| Cost of Revenue | $4,536,771 | $6,170,013 | $6,390,760 | $6,571,626 |
| Gross Profit | $2,577,935 | $3,448,887 | $3,435,011 | $3,397,842 |
| Selling, General and Administrative Expense | $1,916,608 | $2,852,500 | $2,825,468 | $2,898,820 |
| Asset Impairment Charges | — | — | $1,527,726 | $1,527,726 |
| Operating Income (Loss) | $661,327 | $596,387 | $-918,183 | $-2,078,704 |
| Interest and Debt Expense | $201,004 | $321,828 | $290,349 | $278,182 |
| Other Nonoperating Income (Expense) | $-52,095 | $24,715 | $26,310 | $29,149 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $408,228 | $299,274 | $-1,182,222 | $-2,327,737 |
| Income Tax Expense (Benefit) | $94,386 | $48,057 | $96,702 | $62,895 |
| Net Income (Loss) Attributable to Parent | $313,842 | $251,217 | $-1,278,924 | $-2,390,632 |
| Weighted Average Number of Shares Outstanding, Basic | 53,801,000 | 64,977,000 | 63,012,000 | 60,698,000 |
| Weighted Average Number of Shares Outstanding, Diluted | 54,010,000 | 65,074,000 | 63,012,000 | 60,644,000 |
| Participating Securities, Distributed and Undistributed Earnings (Loss), Basic | $6,001 | $9,504 | $4,103 | $-2,150 |
| Net Income (Loss) Available to Common Stockholders, Basic | $307,841 | $241,713 | $-1,283,027 | $-2,388,482 |
| Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted | $5,978 | $9,490 | $4,103 | $4,103 |
| Net Income (Loss) Available to Common Stockholders, Diluted | $307,864 | $241,727 | $-1,283,027 | $-2,388,487 |
| Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | 209,000 | 97,000 | 0 | -54,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $295,336 | $240,571 | $327,347 | $244,692 |
| Accounts Receivable, after Allowance for Credit Loss, Current | $1,888,890 | $1,926,737 | $1,999,021 | $1,969,848 |
| Property, Plant and Equipment, Net | $748,691 | $714,517 | $735,550 | $698,116 |
| Other Assets, Current | $674,423 | $675,116 | $758,135 | $489,238 |
| Goodwill | $5,078,668 | $4,986,967 | $3,671,746 | $2,636,667 |
| Assets, Current | $2,858,649 | $2,842,424 | $3,084,503 | $2,916,737 |
| Finite-Lived Intangible Assets, Net | $2,804,965 | $2,286,940 | $1,960,338 | $1,651,400 |
| Deferred Income Tax Assets, Net | $72,333 | $218,396 | $317,453 | $346,058 |
| Other Assets, Noncurrent | $928,521 | $942,194 | $991,496 | $147,042 |
| Assets | $12,491,827 | $11,991,438 | $10,761,086 | $9,260,769 |
| Long-term Debt, Excluding Current Maturities | $4,939,712 | $4,733,056 | $4,572,889 | $3,925,373 |
| Other Liabilities, Noncurrent | $920,536 | $910,271 | $950,983 | $949,867 |
| Deferred Income Tax Liabilities, Net | $414,246 | $312,574 | $296,519 | $246,476 |
| Liabilities | $8,348,533 | $7,951,714 | $8,016,741 | $7,492,030 |
| Accounts Payable, Current | $243,565 | $209,812 | $244,771 | $221,495 |
| Long-term Debt, Current Maturities | $2,313 | $2,522 | $65,625 | $450,000 |
| Employee-related Liabilities, Current | $731,172 | $706,619 | $764,962 | $680,040 |
| Other Accrued Liabilities, Current | $1,016,406 | $977,314 | $997,198 | $763,409 |
| Taxes Payable, Current | $80,583 | $99,546 | $123,794 | $73,221 |
| Liabilities, Current | $2,074,039 | $1,995,813 | $2,196,350 | $2,370,314 |
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 |
| Common Stock, Value, Issued | $7 | $7 | $7 | $7 |
| Additional Paid in Capital | $3,582,521 | $3,683,608 | $3,783,972 | $3,859,842 |
| Treasury Stock, Value | $271,968 | $421,449 | $610,162 | $657,424 |
| Retained Earnings (Accumulated Deficit) | $1,024,461 | $1,191,871 | $-177,010 | $-1,157,782 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $-191,727 | $-414,313 | $-252,462 | $-275,904 |
| Stockholders' Equity Attributable to Parent | $4,143,294 | $4,039,724 | $2,744,345 | $1,768,739 |
| Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| Preferred Stock, Shares Outstanding | 0 | 0 | 0 | 0 |
| Common Stock, Shares Authorized | 250,000,000 | 250,000,000 | 250,000,000 | 250,000,000 |
| Common Stock, Shares, Issued | 67,883,000 | 68,849,000 | 70,316,000 | 70,679,000 |
| Common Stock, Shares, Outstanding | 65,734,000 | 64,238,000 | 61,739,000 | 60,948,000 |
| Treasury Stock, Common, Shares | 2,149,000 | 4,611,000 | 8,577,000 | 9,731,000 |
| Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents | — | — | $2,057 | $11,133 |
| Restricted Cash and Cash Equivalents | $221,151 | $189,033 | $191,723 | $33,474 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $516,487 | $429,604 | $521,127 | $454,779 |
| Funds Held for Clients | $218,228 | $179,949 | $187,139 | $190,722 |
| Accounts Receivable, Allowance for Credit Loss, Current | $12,533 | $14,307 | $17,443 | $23,829 |
| Accounts Receivable, Credit Loss Expense (Reversal) | $10,236 | $7,057 | $5,738 | $7,384 |
| Accounts Receivable, Allowance for Credit Loss, Writeoff | $2,500 | $5,283 | $2,602 | $2,602 |
| Property, Plant and Equipment, Gross | $1,549,984 | $1,695,716 | $1,913,558 | $1,984,029 |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $801,293 | $981,199 | $1,178,008 | $1,285,913 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $-12,420 | $-17,577 | $26,382 | $-320 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $359,024 | $-86,883 | $91,523 | $-83,707 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $516,487 | $429,604 | $521,127 | $461,190 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $313,842 | $251,217 | $-1,278,924 | $-2,390,632 |
| Net Cash Provided by (Used in) Operating Activities | $678,008 | $667,492 | $806,967 | $787,098 |
| Payments to Acquire Property, Plant, and Equipment | $180,532 | $238,762 | $234,496 | $212,086 |
| Payments to Acquire Businesses, Net of Cash Acquired | $1,914,079 | $5,504 | $15,887 | $15,224 |
| Net Cash Provided by (Used in) Investing Activities | $-2,109,240 | $-244,266 | $-250,383 | $-207,138 |
| Proceeds from Accounts Receivable Securitization | $1,964,000 | $2,191,000 | $2,347,700 | $1,871,200 |
| Repayments of Accounts Receivable Securitization | $2,192,000 | $1,948,500 | $2,181,700 | $1,775,700 |
| Proceeds from Issuance of Senior Long-term Debt | $2,136,987 | $0 | $0 | $599,796 |
| Proceeds from Other Debt | — | $6,369 | $0 | $0 |
| Repayments of Other Debt | — | $7,558 | $828,315 | $822,150 |
| Payments of Debt Issuance Costs | $30,519 | $600 | $4,755 | $4,953 |
| Payment for Contingent Consideration Liability, Financing Activities | — | — | $6,454 | $0 |
| Proceeds from Stock Options Exercised | $7,201 | $5,030 | $3,978 | $3,835 |
| Payment, Tax Withholding, Share-based Payment Arrangement | $17,231 | $13,385 | $20,005 | $20,330 |
| Payments for Repurchase of Common Stock | $63,958 | $136,096 | $168,708 | $99,128 |
| Payments of Dividends | $63,495 | $83,807 | $89,618 | $92,489 |
| Net Cash Provided by (Used in) Financing Activities | $1,802,676 | $-492,532 | $-491,443 | $-663,347 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $142,598 | $282,270 | $299,615 | $299,615 |
| Income Taxes Paid | $217,252 | $298,445 | $270,328 | $270,328 |
| Capital Expenditures Incurred but Not yet Paid | $26,374 | $24,856 | $28,781 | $21,971 |
| Asset Impairment Charges | — | — | $1,527,726 | $1,527,726 |
| Depreciation | $173,463 | $246,920 | $226,101 | $228,623 |
| Amortization of Intangible Assets | $214,832 | $458,925 | $434,332 | $414,197 |
| Share-based Payment Arrangement, Noncash Expense | $62,113 | $96,057 | $96,386 | $90,495 |
| Accounts Receivable, Credit Loss Expense (Reversal) | $10,236 | $7,057 | $5,738 | $7,655 |
| Deferred Income Tax Expense (Benefit) | $-121,711 | $-235,248 | $-154,877 | $-112,270 |
| Amortization of Debt Issuance Costs | $6,089 | $25,276 | $23,548 | $10,215 |
| Pension and Other Postretirement Benefits Cost (Reversal of Cost) | $11,328 | $16,097 | $16,565 | $24,256 |
| Payment for Pension and Other Postretirement Benefits | $12,143 | $4,442 | $4,058 | $4,058 |
| Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | $15,681 | $-29,268 | $-1,958 | $-5,028 |
| Other Noncash Income (Expense) | $-306 | $-1,791 | $-2,152 | $-5,979 |
| Increase (Decrease) in Accounts Receivable | $45,895 | $63,851 | $23,078 | $-71,267 |
| Increase (Decrease) in Accounts Payable | $9,341 | $-25,819 | $28,474 | $1,860 |
| Increase (Decrease) in Other Operating Assets and Liabilities, Net | $-25,897 | $77,220 | $91,160 | $141,607 |